Amedeo's Top 20

Amedeo Smart

Independent Medical Education


09 July 2018

Multidisciplinary Journal Club

  1. Esteban R, Pineda JA, Calleja JL, Casado M, et al.
    Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With HCV genotype 3 Infection and Cirrhosis.
    Gastroenterology 2018.

  1. Busse WW, Bateman ED, Caplan AL, Kelly HW, et al.
    Combined Analysis of Asthma Safety Trials of Long-Acting beta2-Agonists.
    N Engl J Med 2018;378:2497-2505.

  2. Cecconi M, Evans L, Levy M, Rhodes A, et al.
    Sepsis and septic shock.
    Lancet 2018.

  3. Velasquez GE, Brooks MB, Coit JM, Pertinez H, et al.
    Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis: A Randomized Controlled Trial.
    Am J Respir Crit Care Med 2018.

  4. Perez-Risco D, Rodriguez-Temporal D, Valledor-Sanchez I, Alcaide F, et al.
    Evaluation of the Xpert MTB/RIF Ultra Assay for Direct Detection of Mycobacterium tuberculosis Complex in Smear-Negative Extrapulmonary Samples.
    J Clin Microbiol 2018.

  1. Cuadrado A, Llerena S, Cobo C, Pallas JR, et al.
    Microenvironment Eradication of Hepatitis C: A Novel Treatment Paradigm.
    Am J Gastroenterol 2018.

  2. Chang JL, Tsai AC, Musinguzi N, Haberer JE, et al.
    Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study.
    Ann Intern Med 2018.

  3. Hussain M, Fizazi K, Saad F, Rathenborg P, et al.
    Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.
    N Engl J Med 2018;378:2465-2474.

  4. Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, et al.
    Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
    J Clin Oncol 2018.

  5. Given JE, Loane M, Garne E, Addor MC, et al.
    Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study.
    BMJ 2018;361:k2477.

  1. Fulcher JA, Du Y, Zhang TH, Sun R, et al.
    Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir.
    Clin Infect Dis 2018.

  2. Mendoza MCB, Gardner L, Armon C, Rose C, et al.
    Time spent with HIV viral load >1500 copies/mL among patients in HIV care, 2000-2014.
    AIDS 2018.

  3. Briganti A, Fossati N, Catto JWF, Cornford P, et al.
    Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018.
    Eur Urol 2018.

  4. Selak V, Kerr A, Poppe K, Wu B, et al.
    Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy.
    JAMA 2018;319:2507-2520.

  5. Grayhack C, Sheth A, Kirby O, Davis J, et al.
    Evaluating outcomes of mother-infants pairs using dolutegravir for HIV treatment during pregnancy.
    AIDS 2018.

  1. Narula N, Peerani F, Meserve J, Kochhar G, et al.
    Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol 2018.

  2. Bangalore S, Toklu B, Patel N, Feit F, et al.
    Newer Generation Ultra-Thin Strut Drug-Eluting Stents versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease: A Meta-Analysis of Randomized Trials.
    Circulation 2018.

  3. Giordano SH, Temin S, Chandarlapaty S, Crews JR, et al.
    Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.
    J Clin Oncol 2018.

  4. Montgomery ET, Stadler J, Naidoo S, Katz AWK, et al.
    Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results.
    AIDS 2018;32:1517-1525.

  5. Orme RC, Parker WAE, Thomas MR, Judge HM, et al.
    Study of Two Dose Regimens of Ticagrelor Compared with Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease (STEEL-PCI).
    Circulation 2018.


more..


Privacy Policy